Latest Market Risks News

Page 35 of 38
Duxton Farms Limited reported a robust Q2 FY2025, driven by favourable weather conditions and strategic investments, including a share buyback and increased stakes in agricultural ventures. The company recorded a $2.24 million operating cash flow surplus amid mixed crop yields and ongoing diversification.
Ada Torres
Ada Torres
31 Jan 2025
Beacon Minerals delivered a robust December quarter with gold production rising 31% to 6,861 ounces, surpassing guidance and underpinning a strong financial position bolstered by a $10.3 million entitlement issue.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Alliance Nickel Ltd has completed a definitive feasibility study for its NiWest Nickel-Cobalt Project, revealing strong financial metrics, increased ore reserves, and strategic collaborations with global automakers. The project is positioned to become a low-cost, sustainable supplier of high-purity nickel and cobalt for the burgeoning electric vehicle market.
Maxwell Dee
Maxwell Dee
31 Jan 2025
PainChek Ltd reports robust growth with 100,000 contracted licences globally and positive FDA clearance progress, alongside a promising launch of its Infant App targeting a vast new market.
Ada Torres
Ada Torres
31 Jan 2025
Morella Corporation reports significant rubidium and lithium mineralization at its Mt Edon and West Wodgina projects, backed by a successful A$1.4 million capital raise to accelerate exploration in Australia and Nevada.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Australian Gold and Copper Ltd confirms Achilles as a major silver-dominant discovery with exceptional assay results, backed by a strong $17 million cash position. The company is gearing up for an aggressive exploration campaign in 2025 targeting multiple new high-priority zones.
Maxwell Dee
Maxwell Dee
31 Jan 2025
MFF Capital Investments Limited has reported a striking net profit after tax of $381.5 million for the half year ended December 31, 2024, more than doubling last year’s result. The company also announced an increased fully franked interim dividend of 8 cents per share, underscoring its robust financial position and growth trajectory.
Claire Turing
Claire Turing
30 Jan 2025
Argenica Therapeutics has dosed 80% of patients in its Phase 2 stroke trial and gained FDA orphan drug designations for its second candidate, ARG-006. The company reports a cash-positive quarter with $15 million in reserves.
Ada Torres
Ada Torres
30 Jan 2025
Ioneer Ltd has closed a $996 million loan from the U.S. Department of Energy to accelerate its Rhyolite Ridge Lithium-Boron Project in Nevada, following key federal permitting milestones. Construction is targeted for 2025, promising to boost domestic critical mineral supply and create hundreds of jobs.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Capricorn Metals delivered a robust December quarter with rising gold production, record cash flow, and strategic expansions, positioning itself strongly for FY25 targets.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Arafura Rare Earths has secured a pivotal A$200 million investment commitment from the National Reconstruction Fund Corporation, advancing its Nolans Project towards a final investment decision targeted for mid-2025.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Bannerman Energy reports solid progress on its Etango Uranium Project with construction milestones met, a robust cash position, and a bullish uranium market backdrop.
Maxwell Dee
Maxwell Dee
30 Jan 2025